期刊文献+

肥厚型心肌病治疗进展 被引量:1

Therapeutic progress of hypertrophic cardiomyopathy
下载PDF
导出
摘要 肥厚型心肌病是一种原发性心肌非对称肥厚,具有常染色体遗传倾向的心肌病。治疗方法包括药物治疗及非药物治疗。药物治疗仍为目前基本常规治疗,非药物治疗包括手术治疗,双腔起搏器治疗,经皮腔内室间隔心肌消融术,后两种方法是目前研究及开展较多的治疗方法。本文对近几年国内外文献关于非药物治疗的三种方法的优缺点进行综述。 Hypertrophic cardiomyopathy is a primary myocardial disorder with an autosomal pattern of inheritance characterized by inappropriate myocardial. The treatment strategies are drug-therapy and non-drug-therapy. The non-drug-therapy includes surgical myectomy, permanent dual-chamber pacing and percutaneous transluminal septal myocardial ablation. Now the drug-therapy is still the basic therapy. This article reviews the advantages and disadvantages of these three forms of non-drug therapy.
作者 张妮 孙福成
出处 《中国心血管杂志》 2006年第2期146-149,共4页 Chinese Journal of Cardiovascular Medicine
关键词 肥厚型心肌病 手术 起搏器 化学消融 Hypertrophic cardiomyopathy Myeetomy Pacing Myocardial ablation
  • 相关文献

参考文献26

  • 1Knight C, Kurbsan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertropic obstructive cardiomyopathy: outcome in the first series of patients[J]. Circulation, 1997,95 : 2075-2081.
  • 2Louie EK, Edwards LC. Hypertropic cardiomyopathy[J]. Prog Cardiovase Dis, 1994,36 : 275-308.
  • 3Wigle ED, Rakowski H, Kimbau BP, et al. Hypertropic cardiomyopathy clinical spectrum and treatment [J]. Circulation,1995,92:1680-1692.
  • 4Spirito D, Seidman CB, Mckenna WJ, et al. Management of hypertropic cardiomyopathy[J]. N Englj Med, 1997,3: 775-785.
  • 5郑瑾,宋远民,李健.地尔硫联合依那普利治疗肥厚型心肌病临床观察[J].心血管康复医学杂志,2002,11(3):243-245. 被引量:2
  • 6贺海龙,张文勇,薛艳琴,王建华.钙拮抗剂联合硝酸酯类药物对肥厚型心肌病的疗效观察[J].心脏杂志,2003,15(6):570-571. 被引量:1
  • 7Schulte H D,Bo risov K, Gram sch Z H, et al. Management of symptomatic hypertrophic obstructive cardiomyopathy long-term results after surgical therapy[J]. Thorac Cardiovasc Surg, 1999,47: 213-218.
  • 8Seiler C, Hess OM ,Schoenbeck M ,et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy : a retrospective study[J]. J Am Coll Cardiol , 1991,17:634-643.
  • 9Robert A. Surgical versus medical therapy of hypertrophic cardiomyopathy:is the prespective changing [J]. J Am Coll Cardiol, 1991,17: 643-678.
  • 10朱晓东,吴洪斌,胡盛寿,胡宝琏.肥厚性梗阻型心肌病的外科治疗[J].中华胸心血管外科杂志,1997,13(2):73-75. 被引量:5

二级参考文献29

  • 1朱晓东,吴洪斌,胡盛寿,胡宝琏.肥厚性梗阻型心肌病的外科治疗[J].中华胸心血管外科杂志,1997,13(2):73-75. 被引量:5
  • 2颜艳 徐勇勇.医学文献的系统综述方法与meta分析[A].见:孙振球主编.医学统计学[C].北京:人民卫生出版社,2002.499-509.
  • 3Nagueh S F, Ommen S R, Lakkis N M, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001 ,38 : 1701- 1706.
  • 4Qin J X, Shiota T, Lever H M, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol,2001 ,38 : 1994- 2000.
  • 5Firoozi S, Elliott P M, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.Eur Heart J,2002 ,23:1617-1624.
  • 6Sitges M, Shiota T, Lever H M, et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. AmJ Cardiol,2003 ,91:817-821.
  • 7Sherrid M V, Chaudhry F A, Swistel D G. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg, 2003 ,75:620-632.
  • 8Nielsen C D, Spencer W H 3rd. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy.Cardiol Rev,2002,10 : 108 - 118.
  • 9Freedman R A. Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy.Curr Opin Cardiol, 2001,16:58-65.
  • 10朱晓东,心脏外科基础图解,1980年,270页

共引文献26

同被引文献8

  • 1Fujino N, Shimizu M, Ino H, et al. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin Cardiol,2001, 24 : 397-402.
  • 2Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 2001,104:557-567.
  • 3Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation ,2006,24, e858 -862.
  • 4Marian A J, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2001, 33: 655- 670.
  • 5Zhao Y, Meng XM, Wei YJ,et al. Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med,2003,81:297-304.
  • 6Solaro RJ,Rarick HM. Troponin and tropomyosin:proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res, 1998,83:471-480.
  • 7He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A, 1998,95:2509-2514.
  • 8高明明,肖白,胡大一,朱章菱,顼志敏,邵伟,周艳,周桔,刘敬忠.肥厚型心肌病患者血管紧张素转换酶基因型分布[J].中华心血管病杂志,1999,27(6):465-466. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部